Monday, May 10, 2010

While You Were Bailing Out Europe

What's €750 billion among friends? Finance ministers across the continent scrambled this weekend to come up with a (just-don't-call-it-a-) bailout to relieve the ongoing and potentially spreading European debt crisis. But in the pharmaceutical corner of the world, it seems hard news was replaced by management profiles.

While you were recovering from BIO ...

  • Joe Jiminez talks to the FT about settling in as CEO of Novartis, how he works with Dan Vasella, and cost cutting at Big Pharma.

  • The NYT profiles generics giant Teva. The secret to Teva's success? Small offices! (Among other things.)

  • Takeda said this morning that it would co-promote Velcade in Japan. Takeda's Millennium subsidiary originally licensed Japanese rights -- along with a host of other geographic rights -- to J&J's Ortho Biotech in 2003.

image from flickr user irene used under a creative commons license.

No comments: